http://api.archives-ouvertes.fr/search/?fq=halId_s:hal-03253001&fl=title_s,en_title_s,docid,label_s,en_label_s,docType_s,authIdHal_s,halId_s,structId_i,uri_s,keyword_s,en_keyword_s,authLastNameFirstName_s,journalTitle_s,abstract_s,en_abstract_s,producedDate_tdate,producedDateY_i,language_s,fileMain_s&sort=publicationDate_s+desc
authors
- Cuny Thomas
- Graillon Thomas
- Defilles Célines
- Datta Rakesh
- Zhang Shengwen
- Figarella-Branger Dominique
- Dufour Henry
- Mougel Grégory
- Brue Thierry
- Landsman Tanya
- Halem Heather
- Culler Michael
- Barlier Anne
- Saveanu Alexandru
keywords
- Acromegaly
- Cabergoline
- Dopastatin
- Octreotide
- TBR-065
document type
ART
abstract
Somatostatin (SST) and dopamine (DA) inhibit growth hormone (GH) secretion and proliferation of GH-secreting pituitary adenomas (GHomas) through binding to SSTR2 and D2R receptors. Chimeric SST-DA compounds (Dopastatins) display increased potency in inhibiting GH secretion, as compared with individual SST or DA analogs (alone or combined).
more information